Cochrane Kidney and Transplant reviews | Cochrane Kidney and Transplant

Status	Stage
New Updated	Protocol Review

Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease

Diuretics for preventing and treating acute kidney injury

Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kidney disease

Duration of antibacterial treatment for uncomplicated urinary tract infection in women

Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease

Early versus delayed erythropoietin for the anaemia of end-stage kidney disease

Early versus late removal of urinary catheter after kidney transplantation

Early versus late ureteric stent removal after kidney transplantation

Education programmes for people with chronic kidney disease and diabetes

Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function

Effects of peri-operative nonsteroidal anti-inflammatory drugs on post-operative kidney function for adults with normal kidney function

eHealth interventions for people with chronic kidney disease

Emergency interventions for hyperkalaemia

Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis

Erythropoiesis-stimulating agents for preventing acute kidney injury

Exercise training for adult lung transplant recipients

Exercise training for adults undergoing maintenance dialysis

Exercise training for adults with chronic kidney disease

Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi

Fenoldopam for preventing and treating acute kidney injury

Fish oil for kidney transplant recipients

Fluids and diuretics for acute ureteric colic

Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients

Glucose targets for preventing diabetic kidney disease and its progression

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients

Growth hormone for children with chronic kidney disease

Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease

Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease

Heparin and related substances for preventing diabetic kidney disease

High-flux versus low-flux membranes for end-stage kidney disease

HMG CoA reductase inhibitors (statins) for dialysis patients

HMG CoA reductase inhibitors (statins) for kidney transplant recipients

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass

Home versus in-centre haemodialysis for people with kidney failure

Hook F (a traditional Chinese medicine) for primary nephrotic syndrome

Human albumin for intradialytic hypotension in haemodialysis patients

Human albumin infusion for treating oedema in people with nephrotic syndrome

Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function

Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease

Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients

Immunosuppressive agents for treating IgA nephropathy

Immunosuppressive therapy for IgA nephropathy in children

Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome

Immunosuppressive treatment for proliferative lupus nephritis

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease

Intensity of continuous renal replacement therapy for acute kidney injury

Interleukin 2 receptor antagonists for kidney transplant recipients

Intermittent versus continuous renal replacement therapy for acute renal failure in adults

Interventions for atypical haemolytic uraemic syndrome

Interventions for BK virus infection in kidney transplant recipients

Interventions for chronic kidney disease-associated restless legs syndrome

Interventions for chronic non-hypovolaemic hypotonic hyponatraemia

Interventions for covert bacteriuria in children

Interventions for dialysis patients with hepatitis C virus (HCV) infection

Interventions for erythropoietin-resistant anaemia in dialysis patients

Interventions for fatigue in people with kidney failure requiring dialysis

Interventions for focal segmental glomerulosclerosis in adults

Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura

Interventions for HIV-associated nephropathy

Interventions for idiopathic steroid-resistant nephrotic syndrome in children

Interventions for improving health literacy in people with chronic kidney disease

Interventions for improving sleep quality in people with chronic kidney disease

Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients

Interventions for increasing solid organ donor registration

Interventions for itch in people with advanced chronic kidney disease

Interventions for lowering plasma homocysteine levels in dialysis patients

Interventions for lowering plasma homocysteine levels in kidney transplant recipients

Interventions for metabolic bone disease in children with chronic kidney disease

Interventions for minimal change disease in adults with nephrotic syndrome

Interventions for preventing and treating kidney disease in IgA vasculitis

Interventions for preventing bone disease in kidney transplant recipients

Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome

Interventions for preventing haemodialysis dysequilibrium syndrome

Interventions for preventing infection in nephrotic syndrome

Interventions for preventing infectious complications in haemodialysis patients with central venous catheters

Interventions for preventing the progression of autosomal dominant polycystic kidney disease

Interventions for preventing thrombosis in solid organ transplant recipients

Interventions for primary vesicoureteric reflux

Interventions for renal vasculitis in adults

Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts

Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis

Interventions for treating central venous haemodialysis catheter malfunction

Interventions for treating sexual dysfunction in patients with chronic kidney disease

Interventions for weight loss in people with chronic kidney disease who are overweight or obese

Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury

Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units

Laparoendoscopic single-site donor nephrectomy (LESS-DN) versus standard laparoscopic donor nephrectomy

Lipid-lowering agents for nephrotic syndrome

Long-term antibiotics for preventing recurrent urinary tract infection in children

Loop diuretics for patients receiving blood transfusions

Low dialysate sodium levels for chronic haemodialysis

Low protein diets for non-diabetic adults with chronic kidney disease

Metformin for preventing the progression of chronic kidney disease

Methenamine hippurate for preventing urinary tract infections

Modes of administration of antibiotics for symptomatic severe urinary tract infections

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients

Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children

Non-immunosuppressive treatment for IgA nephropathy

Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy

Non-steroidal anti-inflammatory drugs for treating symptomatic uncomplicated urinary tract infections in non-pregnant adult women

Nonsteroidal anti-inflammatory drugs (NSAIDS) versus opioids for acute renal colic

Normal saline versus lower-chloride solutions for kidney transplantation

Normothermic and hypothermic machine perfusion preservation versus static cold storage for deceased donor kidney transplantation

Nutritional support for acute kidney injury

Oestrogens for preventing recurrent urinary tract infection in postmenopausal women

Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease

Oral adsorbents for preventing or delaying the progression of chronic kidney disease

Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis

Parenteral versus oral iron therapy for adults and children with chronic kidney disease

Pentoxifylline for diabetic kidney disease

Percussion, diuresis, and inversion therapy for the passage of lower pole kidney stones following shock wave lithotripsy

Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients

Peritoneal dialysis for acute kidney injury

Peritoneal dialysis versus haemodialysis for people commencing dialysis

Pharmacological interventions for heart failure in people with chronic kidney disease

Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy

Pharmacological interventions for preventing complications in idiopathic hypercalciuria

Pharmacological interventions for the acute management of hyperkalaemia in adults

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D

Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)

Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients

Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients

Potassium binders for chronic hyperkalaemia in people with chronic kidney disease

Pre-emptive correction for haemodialysis arteriovenous access stenosis

Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients

Preoperative vascular access evaluation for haemodialysis patients

Probiotics for preventing urinary tract infection in people with neuropathic bladder

Probiotics for preventing urinary tract infections in adults and children

Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children

Prostaglandin E1 for preventing the progression of diabetic kidney disease

Protein restriction for children with chronic kidney disease

Protein restriction for diabetic kidney disease

Psychosocial interventions for preventing and treating depression in dialysis patients

Quinolones for uncomplicated acute cystitis in women

Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis

Rheum officinale (a traditional Chinese medicine) for chronic kidney disease

Robotic versus laparoscopic versus open nephrectomy for live kidney donors

Routine intraoperative ureteric stenting for kidney transplant recipients

Screening with urinary dipsticks for reducing morbidity and mortality

Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients

Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation

Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children

Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients

Sodium bicarbonate supplements for treating acute kidney injury

Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes

Steroid avoidance or withdrawal for kidney transplant recipients

Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients

Synbiotics, prebiotics and probiotics for people with chronic kidney disease

Synbiotics, prebiotics and probiotics for solid organ transplant recipients

Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients

Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients

Teicoplanin versus vancomycin for proven or suspected infection

Thyroid hormones for acute kidney injury

Tidal versus other forms of peritoneal dialysis for acute kidney injury

Timing of kidney replacement therapy initiation for acute kidney injury

Treatment for hepatitis C virus-associated mixed cryoglobulinaemia

Treatment for peritoneal dialysis-associated peritonitis

Ultrasound use for the placement of haemodialysis catheters

Upper limb exercise for arteriovenous fistula maturation in people requiring permanent haemodialysis access

Urgent-start peritoneal dialysis versus conventional-start peritoneal dialysis for people with chronic kidney disease

Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease

Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease

Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women

Vitamin B and its derivatives for diabetic kidney disease

Vitamin D compounds for people with chronic kidney disease not requiring dialysis

Vitamin D compounds for people with chronic kidney disease requiring dialysis

Blood pressure targets in people with cardiovascular disease

Central venous catheter coating with antiseptics or antibiotics for reducing catheter-related infections in adults

Discharge planning from hospital

Does delaying the initiation or starting calcineurin inhibitors at a lower dose reduce the risk of delayed recovery of a transplanted kidney?New

Does heparin locking prevent blocking of central venous catheters in adults when compared to locking with normal saline?

Does treatment with GLP-1 receptor agonists prevent complications for people with chronic kidney disease and diabetes?

Dressings for the prevention of surgical site infection

Early and late adverse effects on the kidney after treatment for childhood cancer

Effect of decision-support tools on mobile phones on primary health care

End-of-life care pathways for the dying

Exercise interventions for adults after liver transplantation

Exercise-based cardiac rehabilitation for patients following a heart transplantation

Follow-up services to improve the long-term after-effects of a stay in the intensive care unit

Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients

Hepatitis B vaccines achieve antibody production in patients with chronic renal failure, but we do not know if the vaccines are protective

Home-based end-of-life care

How often should dressings on central venous access devices (CVADs) be changed to reduce catheter-related infection?

Improving outcomes for people with multiple chronic conditions

Interventions for preventing of non-melanoma skin cancers in high-risk groups

Interventions for preventing recurrent urinary tract infections during pregnancy

Interventions for the management of dry mouth: topical therapies

Interventions to improve people's drug-taking behaviour with lipid-lowering drugs

Measurement of serum galactomannan to detect invasive aspergillosis in immunocompromised patients

Medical interventions to prevent early graft rejection after liver transplantation

Medical interventions to prevent graft rejection after liver transplantation

Medicines to prevent blockage of vascular access following surgery for formation of arteriovenous fistula or graft

Newborn circumcision for the prevention of urinary tract infections in infancy

Non-drug treatments for dry mouth symptoms

Opiods for restless legs syndrome

Protein restriction for diabetic renal disease

Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes

Shared care across the interface between primary and specialty care in chronic disease management

Skin antisepsis for reducing central venous catheter-related infections

Surgical hand antisepsis to reduce surgical site infection

The effect of a low salt diet on blood pressure and some hormones and lipids in people with normal and elevated blood pressure

Treatment for Anderson-Fabry disease